Back Villumsen, M, Schelde, AB Jimenez-Solem, E (July 2021) 'GLP-1 based therapies and disease course of inflammatory bowel disease', eClinical Medicine, 37/100979
Monitoring strategies should be individualized based on patient risk factors and align with FDA prescribing information, which recommends monitoring heart rate at regular intervals for some GLP-1 receptor agonists
Diagnosis of Diabetic Gastroparesis Diabetic gastroparesis is diagnosed by the presence of upper GI symptoms suggestive of delayed gastric emptying in a diabetic patient, exclusion of mechanical obstruction that could cause upper GI symptoms and the demonstration of delayed gastric emptying
For musculoskeletal indications, the guideline is progressive load reintroduction starting no earlier than 6 to 8 weeks, with full training not before 3 months for significant tendon injuries regardless of how good the patient feels
Both sermorelin peptide and ibutamoren (MK-677) have emerged as compounds in the field of growth hormone optimization